Multicenter Randomized Controlled Trial of APERTO-Paclitaxel Drug-Eluting Balloon Angioplasty Versus Standard Percutaneous Transluminal Angioplasty in Dysfunctional Hemodialysis Grafts and Native Fistulae.

Geert MaleuxEdwin van der LindenRoeland J J HeijboerGian Piero SerafinoAloys F J WüstJohan A DolKaren GabrielsPeter Pattynama

Published in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2023)

APERTO-paclitaxel drug-coated balloon catheter is a safe device to manage dysfunctional hemodialysis access. Compared to conventional angioplasty balloon, the APERTO drug-coated balloon will not result in longer period of adequate hemodialysis circuit functioning. A non-significant benefit of APERTO drug-coated balloon was found in de novo lesions in autologous fistulas.

Keyphrases

randomized controlled trial
peritoneal dialysis
end stage renal disease
chronic kidney disease
stem cells
adverse drug
ultrasound guided
study protocol
bone marrow
emergency department
systematic review
minimally invasive
radiofrequency ablation
electronic health record